Skip to main content
Log in

Process optimization and particle engineering of micronized drug powders via milling

  • Review Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

Process control and optimization is a critical aspect of process analytical technology (PAT), quality by design (QbD), and the implementation of continuous manufacturing procedures. While process control and optimization techniques have been utilized in other manufacturing industries for decades, the pharmaceutical industry has only recently begun to adopt these procedures. Micronization, particularly milling, is a generally low-yield, high-energy consumption process that is well suited for a process optimization mindset. This review discusses optimization of the pharmaceutical milling process through design space development, theoretical and empirical modeling, and monitoring of critical quality attributes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Del Castillo E. Process optimization: a statistical approach. Vol Book, Whole. New York: Springer; 2007, https://doi.org/10.1007/978-0-387-71435-6.

  2. FDA. Guidance for Industry PAT: a framework for innovative pharmaceutical development, manufacuring, and quality assurance. FDA official document. 2004:16. http://www.fda.gov/CDER/guidance/6419fnl.pdf.

  3. International Conference on Harmonisation Expert Working G. Pharmaceutical development Q8(R2). ICH Harmonised Tripartite Guideline. 2009;1–24.

  4. International Conference on Harmonisation Expert Working G. Pharmaceutical quality system Q10. ICH Harmonised Tripartite Guideline. 2008;177–81. doi:EMEA/CHMP/ICH/214732/2007.

  5. International Conference on Harmonisation Expert Working G. Quality risk management Q9. ICH Harmonised Tripartite Guideline. 2005; 1–23. https://doi.org/10.1007/s11095-007-9511-1.

  6. Yu LX, et al. Pharm Res. 2008;25(4):781–91. https://doi.org/10.1007/s11095-007-9511-1.

    Article  CAS  PubMed  Google Scholar 

  7. LX Y, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771–83. https://doi.org/10.1208/s12248-014-9598-3.

    Article  CAS  Google Scholar 

  8. Levin M, Levin M. Pharmaceutical process scale-up. UNKNOWN:Informa Healthcare: New York; 2005.

    Book  Google Scholar 

  9. Myerson AS, Krumme M, Nasr M, Thomas H, Braatz RD. Control systems engineering in continuous pharmaceutical manufacturing May 20–21, 2014 continuous manufacturing symposium. J Pharm Sci. 2015;104(3):832–9. https://doi.org/10.1002/jps.24311.

    Article  CAS  PubMed  Google Scholar 

  10. Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find Exp Clin Pharmacol. 1998;20(3):211–5.

    CAS  PubMed  Google Scholar 

  11. Williams RO, Watts AB, Miller DA. Formulating poorly water soluble drugs. 1st ed., Vol Book, Whole. New York, AAPS Press; 2012. https://doi.org/10.1007/978-1-4614-1144-4.

  12. Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19(12):930–4. https://doi.org/10.1021/ja02086a003.

    Article  Google Scholar 

  13. Bhakay A, Merwade M, Bilgili E, Dave RN. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs. Drug Dev Ind Pharm. 2011;37(8):963–76. https://doi.org/10.3109/03639045.2010.551775.

    Article  CAS  PubMed  Google Scholar 

  14. Hickey AJ, Martonen TB, Yang Y. Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols. Pharm Acta Helv. 1996;71(3):185–90. https://doi.org/10.1016/0031-6865(96)00014-3.

    Article  CAS  PubMed  Google Scholar 

  15. Yang MY, Chan JGY, Chan H-K. Pulmonary drug delivery by powder aerosols. J Control Release. 2014;193:228–40. https://doi.org/10.1016/j.jconrel.2014.04.055.

    Article  CAS  PubMed  Google Scholar 

  16. Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6(1):67–74. https://doi.org/10.1038/nrd2153.

    Article  CAS  PubMed  Google Scholar 

  17. Yalkowsky SH, Bolton S. Particle size and content uniformity. Pharm Res. 1990;7(9):962–6. https://doi.org/10.1023/a:1015958209643.

    Article  CAS  PubMed  Google Scholar 

  18. Huang C-Y, Sherry KM. Prediction of drug particle size and content uniformity in low-dose solid dosage forms. Int J Pharm. 2010;383(1):70–80. https://doi.org/10.1016/j.ijpharm.2009.09.009.

    Article  CAS  PubMed  Google Scholar 

  19. Clement S, Purutyan H. Narrowing down equipment choices for particle-size reduction. Chem Eng Prog. 2002;98:50–4.

    CAS  Google Scholar 

  20. Parrott EL. Milling of pharmaceutical solids. J Pharm Sci. 1974;63(6):813–29. https://doi.org/10.1002/jps.2600630603.

    Article  CAS  PubMed  Google Scholar 

  21. Rumpf H. Physical aspects of comminution and new formulation of a law of comminution. Powder Technol. 1973;7(3):145–59. https://doi.org/10.1016/0032-5910(73)80021-X.

    Article  Google Scholar 

  22. Fatah N. Study and comparison of micronic and nanometric powders: analysis of physical, flow and interparticle properties of powders. Powder Technol. 2009;190(1-2):41–7. https://doi.org/10.1016/j.powtec.2008.04.055.

    Article  CAS  Google Scholar 

  23. Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HDC, Mulder T, et al. Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. J Pharm Sci. 2007;96(5):1282–301. https://doi.org/10.1002/jps.20916.

    Article  CAS  PubMed  Google Scholar 

  24. Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HDC, Mulder T, et al. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics. J Pharm Sci. 2007;96(5):1302–19. https://doi.org/10.1002/jps.20943.

    Article  CAS  PubMed  Google Scholar 

  25. Fisher ES. Milling of active pharmaceutical ingredients. Encyclopedia of pharmaceutical technology, 3rd Edition. Taylor & Francis Online; 2013. p. 2339–51.

  26. Vogel L, Peukert W. Breakage behaviour of different materials—construction of a mastercurve for the breakage probability. Powder Technol. 2003;129(1):101–10. https://doi.org/10.1016/S0032-5910(02)00217-6.

    Article  CAS  Google Scholar 

  27. Yokoyama T, Inoue Y. Chapter 10 Selection of fine grinding mills. Handbook of powder technology. 2007; 12:487–508. https://doi.org/10.1016/S0167-3785(07)12013-3.

  28. Rasenack N, Müller BW. Micron-size drug particles: common and novel micronization techniques. Pharm Dev Technol. 2004;9(1):1–13. https://doi.org/10.1081/PDT-120027417.

    Article  CAS  PubMed  Google Scholar 

  29. Saleem IY, Smyth HDC. Micronization of a soft material: air-jet and micro-ball milling. AAPS PharmSciTech. 2010;11(4):1642–9. https://doi.org/10.1208/s12249-010-9542-5.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Vatsaraj NB, Gao D, Kowalski DL. Optimization of the operating conditions of a lab scale Aljet mill using lactose and sucrose: a technical note. AAPS PharmSciTech. 2003;4(2):141–6. https://doi.org/10.1208/pt040227.

    Article  PubMed Central  Google Scholar 

  31. Chamayou A, Dodds JA. Chapter 8 Air jet milling. Handbook of powder technology 2007;12:421–35. https://doi.org/10.1016/S0167-3785(07)12011-X.

  32. Teng S, Wang P, Zhu L, Young MW, Gogos CG. Experimental and numerical analysis of a lab-scale fluid energy mill. Powder Technol. 2009;195(1):31–9. https://doi.org/10.1016/j.powtec.2009.05.013.

    Article  CAS  Google Scholar 

  33. Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62(11):1569–79. https://doi.org/10.1111/j.2042-7158.2010.01022.x.

    Article  CAS  PubMed  Google Scholar 

  34. Singh SK, Srinivasan KK, Gowthamarajan K, Singare DS, Prakash D, Gaikwad NB. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur J Pharm Biopharm. 2011;78(3):441–6. https://doi.org/10.1016/j.ejpb.2011.03.014.

    Article  CAS  PubMed  Google Scholar 

  35. Tavares LM. Chapter 1 Breakage of single particles: quasi-static. In: Agba D, Salman MG, Michael JH, editors. Handbook of powder technology. Amsterdam: Elsevier Science B.V.; 2007. p. 3–68.

    Google Scholar 

  36. Tavares LM, King RP. Single-particle fracture under impact loading. Int J Miner Process. 1998;54(1):1–28. https://doi.org/10.1016/S0301-7516(98)00005-2.

    Article  CAS  Google Scholar 

  37. Chau KT, Wu S. Chapter 2 Impact breakage of single particles: double impact test. In: Agba D, Salman MG, Michael JH, editors. Handbook of powder technology. Amsterdam: Elsevier Science B.V.; 2007. p. 69–85.

    Google Scholar 

  38. Ghadiri M, Kwan CC, Ding Y. Chapter 14 Analysis of milling and the role of feed properties. In: Agba D, Salman MG, Michael JH, editors. Handbook of powder technology. Amsterdam: Elsevier Science B.V.; 2007. p. 605–34.

    Google Scholar 

  39. Weerasekara NS, Powell MS, Cleary PW, Tavares LM, Evertsson M, Morrison RD, et al. The contribution of DEM to the science of comminution. Powder Technol. 2013;248:3–4. https://doi.org/10.1016/j.powtec.2013.05.032.

    Article  CAS  Google Scholar 

  40. Kanda Y, Sano S, Yashima S. A consideration of grinding limit based on fracture mechanics. Powder Technol. 1986;48(3):263–7. https://doi.org/10.1016/0032-5910(86)80051-1.

    Article  CAS  Google Scholar 

  41. Annapragada A, Adjei A. Numerical simulation of milling processes as an aid to process design. Int J Pharm. 1996;136(1-2):1–11. https://doi.org/10.1016/0378-5173(96)04465-1.

    Article  CAS  Google Scholar 

  42. Ghadiri M, Zhang Z. Impact attrition of particulate solids. Part 1: a theoretical model of chipping. Chem Eng Sci. 2002;57(17):3659–69. https://doi.org/10.1016/S0009-2509(02)00240-3.

    Article  CAS  Google Scholar 

  43. Kwan CC, Chen YQ, Ding YL, Papadopoulos DG, Bentham AC, Ghadiri M. Development of a novel approach towards predicting the milling behaviour of pharmaceutical powders. Eur J Pharm Sci. 2004;23(4-5):327–36. https://doi.org/10.1016/j.ejps.2004.08.006.

    Article  CAS  PubMed  Google Scholar 

  44. García-Muñoz S, Dolph S, Ward HW. Handling uncertainty in the establishment of a design space for the manufacture of a pharmaceutical product. Comput Chem Eng. 2010;34(7):1098–107. https://doi.org/10.1016/j.compchemeng.2010.02.027.

    Article  CAS  Google Scholar 

  45. Lepore J, Spavins J. PQLI design space. J Pharm Innov. 2008;3(2):79–87. https://doi.org/10.1007/s12247-008-9034-2.

    Article  Google Scholar 

  46. Boukouvala F, Muzzio FJ, Ierapetritou MG. Design space of pharmaceutical processes using data-driven-based methods. J Pharm Innov. 2010;5(3):119–37. https://doi.org/10.1007/s12247-010-9086-y.

    Article  Google Scholar 

  47. Rantanen J, Khinast J. The future of pharmaceutical manufacturing sciences. J Pharm Sci. 2015;104(11):3612–38. https://doi.org/10.1002/jps.24594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Yazdi AK, Smyth HDC. Implementation of design of experiments approach for the micronization of a drug with a high brittle–ductile transition particle diameter. Drug Dev Ind Pharm. 2017;43(3):364–71. https://doi.org/10.1080/03639045.2016.1253727.

    Article  CAS  PubMed  Google Scholar 

  49. Midoux N, Hošek P, Pailleres L, Authelin J. Micronization of pharmaceutical substances in a spiral jet mill. Powder Technol. 1999;104(2):113–20. https://doi.org/10.1016/S0032-5910(99)00052-2.

    Article  CAS  Google Scholar 

  50. Cho H, Kwon J, Kim K, Mun M. Optimum choice of the make-up ball sizes for maximum throughput in tumbling ball mills. Powder Technol. 2013;246:625–34. https://doi.org/10.1016/j.powtec.2013.06.026.

    Article  CAS  Google Scholar 

  51. Rittinger PRv. Lehrbuch der Aufbereitungskunde in ihrer neuesten Entwicklung und Ausbindung systematisch dargestellt. vol Book, Whole. Germany; 1867.

  52. Austin LG. A commentary on the Kick, Bond and Rittinger laws of grinding. Powder Technol. 1973;7(6):315–7. https://doi.org/10.1016/0032-5910(73)80042-7.

    Article  Google Scholar 

  53. Bond FC. The third theory of communition. Trans Metall Soc AIME. 1952;193:484–94.

  54. Chen Y, Ding Y, Papadopoulos DG, Ghadiri M. Energy-based analysis of milling alpha-lactose monohydrate. J Pharm Sci. 2004;93(4):886–95. https://doi.org/10.1002/jps.10568.

    Article  CAS  PubMed  Google Scholar 

  55. Austin LG, Bhatia VK. Experimental methods for grinding studies in laboratory mills. Powder Technol. 1972;5(5):261–6. https://doi.org/10.1016/0032-5910(72)80029-9.

    Article  CAS  Google Scholar 

  56. Austin LG. Introduction to the mathematical description of grinding as a rate process. Powder Technol. 1971;5(1):1–17. https://doi.org/10.1016/0032-5910(71)80064-5.

    Article  Google Scholar 

  57. Capece M, Dave R, Bilgili E. A rational function approximation to the effectiveness factor for multi-particle interactions in dense-phase dry milling. Powder Technol. 2012;230:67–76. https://doi.org/10.1016/j.powtec.2012.06.054.

    Article  CAS  Google Scholar 

  58. Capece M, Bilgili E, Dave RN. Emergence of falsified kinetics as a consequence of multi-particle interactions in dense-phase comminution processes. Chem Eng Sci. 2011;66(22):5672–83. https://doi.org/10.1016/j.ces.2011.08.001.

    Article  CAS  Google Scholar 

  59. Austin LG, Bagga P. An analysis of fine dry grinding in ball mills. Powder Technol. 1981;28(1):83–90. https://doi.org/10.1016/0032-5910(81)87014-3.

    Article  Google Scholar 

  60. Gutsche O, Fuerstenau DW. Fracture kinetics of particle bed comminution—ramifications for fines production and mill optimization. Powder Technol. 1999;105(1):113–8. https://doi.org/10.1016/S0032-5910(99)00125-4.

    Article  CAS  Google Scholar 

  61. Bilgili E, Yepes J, Scarlett B. Formulation of a non-linear framework for population balance modeling of batch grinding: beyond first-order kinetics. Chem Eng Sci. 2006;61(1):33–44. https://doi.org/10.1016/j.ces.2004.11.060.

    Article  CAS  Google Scholar 

  62. Capece M, Bilgili E, Dave R. Identification of the breakage rate and distribution parameters in a non-linear population balance model for batch milling. Powder Technol. 2011;208(1):195–204. https://doi.org/10.1016/j.powtec.2010.12.019.

    Article  CAS  Google Scholar 

  63. Ketterhagen WR, am Ende MT, Hancock BC. Process modeling in the pharmaceutical industry using the discrete element method. J Pharm Sci. 2009;98(2):442–70. https://doi.org/10.1002/jps.21466.

    Article  CAS  PubMed  Google Scholar 

  64. Brosh T, Kalman H, Levy A, Peyron I, Ricard F. DEM–CFD simulation of particle comminution in jet-mill. Powder Technol. 2014;257:104–12. https://doi.org/10.1016/j.powtec.2014.02.043.

    Article  CAS  Google Scholar 

  65. Afolabi A, Akinlabi O, Bilgili E. Impact of process parameters on the breakage kinetics of poorly water-soluble drugs during wet stirred media milling: a microhydrodynamic view. Eur J Pharm Sci. 2014;51:75–86. https://doi.org/10.1016/j.ejps.2013.09.002.

    Article  CAS  PubMed  Google Scholar 

  66. Burgess DJ, Duffy E, Etzler F, Hickey AJ. Particle size analysis: AAPS workshop report, cosponsored by the Food and Drug Administration and the United States Pharmacopeia. AAPS J. 2004;6:e20. https://doi.org/10.1208/aapsj060320.

    Article  PubMed  Google Scholar 

  67. Yu W, Muteki K, Zhang L, Kim G. Prediction of bulk powder flow performance using comprehensive particle size and particle shape distributions. J Pharm Sci. 2011;100(1):284–93. https://doi.org/10.1002/jps.22254.

    Article  CAS  PubMed  Google Scholar 

  68. Ward G, Schultz R. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm Res. 1995;12(5):773–779.

  69. Huttenrauch R, Fricke S, Zielke P. Mechanical activation of pharmaceutical systems. Pharm Res. 1985;2(6):302–6. https://doi.org/10.1023/A:1016397719020.

    Article  CAS  PubMed  Google Scholar 

  70. Saleki-Gerhardt A, Ahlneck C, Zografi G. Assessment of disorder in crystalline solids. Int J Pharm. 1994;101(3):237–47. https://doi.org/10.1016/0378-5173(94)90219-4.

    Article  CAS  Google Scholar 

  71. Chamarthy SP, Pinal R. The nature of crystal disorder in milled pharmaceutical materials. Colloids Surf A Physicochem Eng Asp. 2008;331(1):68–75. https://doi.org/10.1016/j.colsurfa.2008.06.040.

    Article  CAS  Google Scholar 

  72. Chikhalia V, Forbes RT, Storey RA, Ticehurst M. The effect of crystal morphology and mill type on milling induced crystal disorder. Eur J Pharm Sci. 2006;27(1):19–26. https://doi.org/10.1016/j.ejps.2005.08.013.

    Article  CAS  PubMed  Google Scholar 

  73. Silva AFT, Burggraeve A, Denon Q, Van Der Meeren P, Sandler N, Van Den Kerkhof T, et al. Particle sizing measurements in pharmaceutical applications: comparison of in-process methods versus off-line methods. Eur J Pharm Biopharm. 2013;85(3):1006–18. https://doi.org/10.1016/j.ejpb.2013.03.032.

    Article  PubMed  Google Scholar 

  74. Kumar V, Taylor MK, Mehrotra A, Stagner WC. Real-time particle size analysis using focused beam reflectance measurement as a process analytical technology tool for a continuous granulation–drying–milling process. AAPS PharmSciTech. 2013;14(2):523–30. https://doi.org/10.1208/s12249-013-9934-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. De Beer T, Burggraeve A, Fonteyne M, Saerens L, Remon JP, Vervaet C. Near infrared and Raman spectroscopy for the in-process monitoring of pharmaceutical production processes. Int J Pharm. 2011;417(1-2):32–47. https://doi.org/10.1016/j.ijpharm.2010.12.012.

    Article  CAS  PubMed  Google Scholar 

  76. Gamble JF, Tobyn M, Hamey R. Application of image-based particle size and shape characterization systems in the development of small molecule pharmaceuticals. J Pharm Sci. 2015;104(5):1563–74. https://doi.org/10.1002/jps.24382.

    Article  CAS  PubMed  Google Scholar 

  77. Nalluri VR, Schirg P, Gao X, Virdis A, Imanidis G, Kuentz M. Different modes of dynamic image analysis in monitoring of pharmaceutical dry milling process. Int J Pharm. 2010;391(1–2):107–14. https://doi.org/10.1016/j.ijpharm.2010.02.027.

    Article  CAS  PubMed  Google Scholar 

  78. Inam MA, Ouattara S, Frances C. Effects of concentration of dispersions on particle sizing during production of fine particles in wet grinding process. Powder Technol. 2011;208(2):329–36. https://doi.org/10.1016/j.powtec.2010.08.025.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. D. C. Smyth.

Ethics declarations

Conflict of interest

The author (HDCS) of this paper consults for and has equity ownership in Respira Therapeutics and Nob Hill Therapeutics on inhaled product development. The terms of this arrangement have been reviewed and approved by the University of Texas at Austin in accordance with its policy on objectivity in research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brunaugh, A., Smyth, H.D.C. Process optimization and particle engineering of micronized drug powders via milling. Drug Deliv. and Transl. Res. 8, 1740–1750 (2018). https://doi.org/10.1007/s13346-017-0444-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-017-0444-x

Keywords

Navigation